News
2don MSN
Indian film posters, initially hand-painted artworks, served as vital promotional tools, captivating audiences with vivid ...
One of the most striking things about Bungie’s Marathonis its presentation. The sci-fi extraction shooter combines bleak ...
ASC47 is an adipose-targeted, ultra-long-acting subcutaneously (SQ) injected thyroid hormone receptor beta (THRβ) selective small molecule agonist, discovered and developed in-house at Ascletis. ASC47 ...
Session A-2 Room 339: Leverage AI in Psychology: Finding a Use Case Presentation 1: Finding a Use Case: Building a Scheduling GPT: Olivia Velez, Psychology Presentation 2: Finding a Use Case: Natural ...
MERIT, Your Clinical Endpoint Expert We’re proud to offer ORC™ as a novel way of measuring disease progression that may support new and existing treatments for Dry AMD.”— Dr. David Bingama... "Kalkine ...
The poster, titled “Outer Retina-Choroid en ... Ophthalmology of MERIT. About the Presentation: • Title: “Outer Retina-Choroid en face Image, ORC™: Characterization of A Novel Morphologic ...
Gain Therapeutics' lead drug candidate, GT-02287, is in clinical development for the treatment of Parkinson's disease (PD) with or without a GBA1 mutation. The orally administered, brain-penetrant ...
NEUVOGEN Announces Poster Presentation at the American Association of Cancer Research Annual Meeting
SAN DIEGO, April 29, 2025 /PRNewswire/ -- NEUVOGEN, Inc. ("NEUVOGEN THERAPEUTICS" or "NEUVOGEN"), a San Diego based biotechnology company, will present data that its next generation whole tumor ...
Thousand Oaks, Calif.-based Capsida Biotherapeutics (Capsida) has announced its slate of seven scientific presentations, three oral and four in poster form, that have been accepted for the 28th Annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results